story of the week
Myocarditis After COVID-19 BNT162b2 mRNA Vaccine in Israel
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Myocarditis After BNT162b2 mRNA Vaccine Against Covid-19 in Israel
N. Engl. J. Med 2021 Oct 06;[EPub Ahead of Print], D Mevorach, E Anis, N Cedar, M Bromberg, EJ Haas, E Nadir, S Olsha-Castell, D Arad, T Hasin, N Levi, R Asleh, O Amir, K Meir, D Cohen, R Dichtiar, D Novick, Y Hershkovitz, R Dagan, I Leitersdorf, R Ben-Ami, I Miskin, W Saliba, K Muhsen, Y Levi, MS Green, L Keinan-Boker, S Alroy-PreisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.